{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:40Z","timestamp":1786986940828,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Research Council of Shiraz University of Medical Sciences, Shiraz, Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clnu.2020.11.037","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T06:02:41Z","timestamp":1607407361000},"page":"2999-3005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Laleh","family":"Mahmoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Al-Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Niknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clnu.2020.11.037_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of nonalcoholic fatty liver disease: a global perspective","volume":"28","author":"Lazo","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.clnu.2020.11.037_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.clnu.2020.11.037_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2013.07.033","article-title":"NAFLD leads to liver cancer: do we have sufficient evidence?","volume":"345","author":"Duan","year":"2014","journal-title":"Canc Lett"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.037_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.clnu.2020.11.037_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000336669","article-title":"Nonalcoholic fatty liver disease\/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment","volume":"30","author":"Mili\u0107","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.clnu.2020.11.037_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.anndiagpath.2018.09.009","article-title":"Nonalcoholic fatty liver disease (NAFLD): diagnosis, pitfalls, and staging","volume":"37","author":"Koch","year":"2018","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.clnu.2020.11.037_bib7","series-title":"Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease","year":"1980"},{"issue":"2","key":"10.1016\/j.clnu.2020.11.037_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-126-2-199701150-00008","article-title":"Nonalcoholic steatohepatitis","volume":"126","author":"Sheth","year":"1997","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.clnu.2020.11.037_bib9","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.6099","article-title":"Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic fatty liver disease: a randomized controlled pilot study","volume":"12","author":"Hajiaghamohammadi","year":"2012","journal-title":"Hepat Mon"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.037_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12876-017-0652-3","article-title":"Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study","volume":"17","author":"Honda","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"13","key":"10.1016\/j.clnu.2020.11.037_bib11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/hepr.12887","article-title":"Ezetimibe for the treatment of non-alcoholic fatty liver disease: a meta-analysis","volume":"47","author":"Nakade","year":"2017","journal-title":"Hepatol Res : J Jap Soc Hepatol"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.037_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/apt.12377","article-title":"Meta-analysis: vitamin D and non-alcoholic fatty liver disease","volume":"38","author":"Eliades","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.037_bib13","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2004-1024","article-title":"Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease","volume":"90","author":"Angelico","year":"2005","journal-title":"J\u00a0Clinic Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.clnu.2020.11.037_bib14","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","article-title":"Hypovitaminosis D is associated with insulin resistance and \u03b2 cell dysfunction","volume":"79","author":"Chiu","year":"2004","journal-title":"Am J Clinic Nutr"},{"issue":"5","key":"10.1016\/j.clnu.2020.11.037_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-152-5-201003020-00009","article-title":"Systematic review: vitamin D and cardiometabolic outcomes","volume":"152","author":"Pittas","year":"2010","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.clnu.2020.11.037_bib16","first-page":"17221","article-title":"Association between vitamin D and non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: results from a meta-analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.037_bib17","first-page":"765","article-title":"Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential","volume":"13","author":"Bikle","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clnu.2020.11.037_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-010510-100611","article-title":"Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D","volume":"51","author":"Krishnan","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.037_bib19","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/art.24329","article-title":"GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis","volume":"60","author":"van Hamburg","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.clnu.2020.11.037_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1010015013211","article-title":"Vitamin D as a cytokine and hematopoetic factor","volume":"2","author":"Hewison","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.037_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.dsx.2018.03.006","article-title":"Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: a randomized double blind placebo controlled trial","volume":"12","author":"Dabbaghmanesh","year":"2018","journal-title":"Diab Metabol Synd"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.037_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2214\/ajr.145.4.753","article-title":"Characteristic sonographic signs of hepatic fatty infiltration","volume":"145","author":"Quinn","year":"1985","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.037_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.037_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15171\/mejdd.2020.159","article-title":"Upper normal limit of serum alanine aminotransferase and its association with metabolic risk factors in pars cohort study","volume":"12","author":"Sehatpour","year":"2020","journal-title":"Mid East J Dig Dis"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.037_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatol"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.037_bib26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatol"},{"issue":"7","key":"10.1016\/j.clnu.2020.11.037_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetol"},{"key":"10.1016\/j.clnu.2020.11.037_bib28","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee","volume":"854","year":"1995","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"25 Part B","key":"10.1016\/j.clnu.2020.11.037_bib29","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American college of cardiology\/American heart association task force on practice guidelines and the obesity society","volume":"63","author":"Jensen","year":"2014","journal-title":"J\u00a0Am Col Cardiol"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.037_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.106.176158","article-title":"Diet and lifestyle recommendations revision 2006: a scientific statement from the American heart association nutrition committee","volume":"114","author":"Lichtenstein","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clnu.2020.11.037_bib31","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.clnu.2020.11.037_bib32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ajg.2016.51","article-title":"Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-\u03baB?","volume":"111","author":"Nelson","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.clnu.2020.11.037_bib33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/BF00422375","article-title":"Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians","volume":"38","author":"Boucher","year":"1995","journal-title":"Diabetol"},{"issue":"8","key":"10.1016\/j.clnu.2020.11.037_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1017\/S0007114511006830","article-title":"Effect of vitamin D 3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats","volume":"108","author":"George","year":"2012","journal-title":"Br J Nutr"},{"issue":"8","key":"10.1016\/j.clnu.2020.11.037_bib35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40618-015-0315-6","article-title":"Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?","volume":"38","author":"Targher","year":"2015","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.037_bib36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hep.24737","article-title":"Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation","volume":"55","author":"Roth","year":"2012","journal-title":"Hepatol"},{"issue":"8","key":"10.1016\/j.clnu.2020.11.037_bib37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.intimp.2007.03.007","article-title":"Calcitriol inhibits hepatocyte apoptosis in rat allograft by regulating apoptosis-associated genes","volume":"7","author":"Zhang","year":"2007","journal-title":"Int Immunopharm"},{"issue":"5","key":"10.1016\/j.clnu.2020.11.037_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/liv.12122","article-title":"1, 25-dihydroxyvitamin D3 and its nuclear receptor repress human \u03b11 (I) collagen expression and type I collagen formation","volume":"33","author":"Potter","year":"2013","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.clnu.2020.11.037_bib39","first-page":"496","article-title":"Vitamin D and the liver\u2014correlation or cause?","volume":"10","author":"Keane","year":"2018","journal-title":"Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2020.11.037_bib40","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/jgh.12541","article-title":"Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity","volume":"29","author":"Black","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clnu.2020.11.037_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2010.11.028","article-title":"Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats","volume":"55","author":"Nakano","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.037_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3350\/cmh.2016.22.1.146","article-title":"The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease","volume":"22","author":"Chung","year":"2016","journal-title":"Clin Mol Hepatol"},{"issue":"3 Special","key":"10.1016\/j.clnu.2020.11.037_bib43","first-page":"1343","article-title":"Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients","volume":"32","author":"Hussain","year":"2019","journal-title":"Pak J Pharm Sci"},{"issue":"6","key":"10.1016\/j.clnu.2020.11.037_bib44","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clnu.2016.09.020","article-title":"Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: randomized, controlled, double-blind trial","volume":"36","author":"Lorvand Amiri","year":"2017","journal-title":"Clinic Nutr (Edinburgh, Scotland)"},{"issue":"1","key":"10.1016\/j.clnu.2020.11.037_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-014-0336-5","article-title":"Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial","volume":"47","author":"Sharifi","year":"2014","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.clnu.2020.11.037_bib46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1172\/JCI106538","article-title":"Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat","volume":"50","author":"Rosenstreich","year":"1971","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.clnu.2020.11.037_bib47","first-page":"631","article-title":"Regression of non-alcoholic fatty liver by vitamin D supplement: a double-blind randomized controlled clinical trial","volume":"19","author":"Lorvand Amiri","year":"2016","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.clnu.2020.11.037_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12916-016-0638-y","article-title":"No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial","volume":"14","author":"Barchetta","year":"2016","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.clnu.2020.11.037_bib49","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1080\/00365521.2018.1501091","article-title":"Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study","volume":"53","author":"Geier","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clnu.2020.11.037_bib50","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420306580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420306580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:07:49Z","timestamp":1759367269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561420306580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0261561420306580"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2020.11.037","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2020.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}